nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—CYP3A4—prostate cancer	0.287	1	CbGaD
Clorazepate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0954	0.207	CbGbCtD
Clorazepate—CYP3A4—Bicalutamide—prostate cancer	0.0501	0.109	CbGbCtD
Clorazepate—CYP3A4—Estramustine—prostate cancer	0.0466	0.101	CbGbCtD
Clorazepate—CYP3A4—Abiraterone—prostate cancer	0.0415	0.09	CbGbCtD
Clorazepate—CYP3A4—Flutamide—prostate cancer	0.0415	0.09	CbGbCtD
Clorazepate—CYP3A4—Cabazitaxel—prostate cancer	0.0307	0.0666	CbGbCtD
Clorazepate—CYP3A4—Estrone—prostate cancer	0.03	0.0651	CbGbCtD
Clorazepate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0268	0.058	CbGbCtD
Clorazepate—CYP3A4—Conjugated Estrogens—prostate cancer	0.0196	0.0426	CbGbCtD
Clorazepate—CYP3A4—Mitoxantrone—prostate cancer	0.0179	0.0387	CbGbCtD
Clorazepate—CYP3A4—Estradiol—prostate cancer	0.0173	0.0374	CbGbCtD
Clorazepate—CYP3A4—Prednisone—prostate cancer	0.0148	0.0321	CbGbCtD
Clorazepate—CYP3A4—Etoposide—prostate cancer	0.0113	0.0244	CbGbCtD
Clorazepate—CYP3A4—Docetaxel—prostate cancer	0.0103	0.0223	CbGbCtD
Clorazepate—CYP3A4—Doxorubicin—prostate cancer	0.00768	0.0166	CbGbCtD
Clorazepate—Slurred speech—Estradiol—prostate cancer	0.00386	0.0225	CcSEcCtD
Clorazepate—Irritability—Estrone—prostate cancer	0.00323	0.0189	CcSEcCtD
Clorazepate—Irritability—Estradiol valerate/Dienogest—prostate cancer	0.00282	0.0165	CcSEcCtD
Clorazepate—Drowsiness—Flutamide—prostate cancer	0.00241	0.0141	CcSEcCtD
Clorazepate—Tension—Estrone—prostate cancer	0.002	0.0117	CcSEcCtD
Clorazepate—Nervousness—Estrone—prostate cancer	0.00198	0.0116	CcSEcCtD
Clorazepate—Tension—Nilutamide—prostate cancer	0.00186	0.0109	CcSEcCtD
Clorazepate—Tension—Flutamide—prostate cancer	0.00185	0.0108	CcSEcCtD
Clorazepate—Nervousness—Nilutamide—prostate cancer	0.00184	0.0107	CcSEcCtD
Clorazepate—Irritability—Ethinyl Estradiol—prostate cancer	0.00183	0.0107	CcSEcCtD
Clorazepate—Nervousness—Flutamide—prostate cancer	0.00183	0.0107	CcSEcCtD
Clorazepate—Dysarthria—Estradiol—prostate cancer	0.00182	0.0107	CcSEcCtD
Clorazepate—Tension—Estradiol valerate/Dienogest—prostate cancer	0.00175	0.0102	CcSEcCtD
Clorazepate—Nervousness—Estradiol valerate/Dienogest—prostate cancer	0.00173	0.0101	CcSEcCtD
Clorazepate—Lorazepam—UGT2B15—prostate cancer	0.00161	0.168	CrCbGaD
Clorazepate—Vision blurred—Degarelix—prostate cancer	0.00159	0.00931	CcSEcCtD
Clorazepate—Dry mouth—Nilutamide—prostate cancer	0.00158	0.00921	CcSEcCtD
Clorazepate—Insomnia—Estramustine—prostate cancer	0.00158	0.0092	CcSEcCtD
Clorazepate—Confusional state—Flutamide—prostate cancer	0.00155	0.00906	CcSEcCtD
Clorazepate—Insomnia—Abiraterone—prostate cancer	0.00153	0.00894	CcSEcCtD
Clorazepate—Irritability—Conjugated Estrogens—prostate cancer	0.00149	0.00872	CcSEcCtD
Clorazepate—Fatigue—Abiraterone—prostate cancer	0.00146	0.00852	CcSEcCtD
Clorazepate—Dry mouth—Degarelix—prostate cancer	0.00141	0.00823	CcSEcCtD
Clorazepate—Insomnia—Nilutamide—prostate cancer	0.0014	0.00817	CcSEcCtD
Clorazepate—Insomnia—Flutamide—prostate cancer	0.00139	0.00813	CcSEcCtD
Clorazepate—Somnolence—Flutamide—prostate cancer	0.00137	0.00799	CcSEcCtD
Clorazepate—Tension—Bicalutamide—prostate cancer	0.00134	0.00784	CcSEcCtD
Clorazepate—Nervousness—Bicalutamide—prostate cancer	0.00133	0.00776	CcSEcCtD
Clorazepate—Dry mouth—Cabazitaxel—prostate cancer	0.00133	0.00775	CcSEcCtD
Clorazepate—Fatigue—Flutamide—prostate cancer	0.00133	0.00775	CcSEcCtD
Clorazepate—Confusional state—Cabazitaxel—prostate cancer	0.00131	0.00766	CcSEcCtD
Clorazepate—Feeling abnormal—Nilutamide—prostate cancer	0.00127	0.00744	CcSEcCtD
Clorazepate—Feeling abnormal—Flutamide—prostate cancer	0.00127	0.00741	CcSEcCtD
Clorazepate—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00125	0.00731	CcSEcCtD
Clorazepate—Insomnia—Degarelix—prostate cancer	0.00125	0.00729	CcSEcCtD
Clorazepate—Drowsiness—Goserelin—prostate cancer	0.00122	0.00711	CcSEcCtD
Clorazepate—Asthenia—Abiraterone—prostate cancer	0.00121	0.00709	CcSEcCtD
Clorazepate—Irritability—Estradiol—prostate cancer	0.00119	0.00698	CcSEcCtD
Clorazepate—Fatigue—Degarelix—prostate cancer	0.00119	0.00695	CcSEcCtD
Clorazepate—Dry mouth—Bicalutamide—prostate cancer	0.00114	0.00665	CcSEcCtD
Clorazepate—Feeling abnormal—Degarelix—prostate cancer	0.00114	0.00665	CcSEcCtD
Clorazepate—Dysarthria—Capecitabine—prostate cancer	0.00114	0.00664	CcSEcCtD
Clorazepate—Confusional state—Bicalutamide—prostate cancer	0.00112	0.00657	CcSEcCtD
Clorazepate—Fatigue—Cabazitaxel—prostate cancer	0.00112	0.00655	CcSEcCtD
Clorazepate—Asthenia—Nilutamide—prostate cancer	0.00111	0.00648	CcSEcCtD
Clorazepate—Asthenia—Flutamide—prostate cancer	0.0011	0.00645	CcSEcCtD
Clorazepate—Dizziness—Estrone—prostate cancer	0.0011	0.00643	CcSEcCtD
Clorazepate—Rash—Estramustine—prostate cancer	0.0011	0.00642	CcSEcCtD
Clorazepate—Dermatitis—Estramustine—prostate cancer	0.0011	0.00641	CcSEcCtD
Clorazepate—Headache—Estramustine—prostate cancer	0.00109	0.00637	CcSEcCtD
Clorazepate—Feeling abnormal—Cabazitaxel—prostate cancer	0.00107	0.00626	CcSEcCtD
Clorazepate—Rash—Abiraterone—prostate cancer	0.00107	0.00623	CcSEcCtD
Clorazepate—Dermatitis—Abiraterone—prostate cancer	0.00107	0.00622	CcSEcCtD
Clorazepate—Rash—Estrone—prostate cancer	0.00105	0.00613	CcSEcCtD
Clorazepate—Dermatitis—Estrone—prostate cancer	0.00105	0.00612	CcSEcCtD
Clorazepate—Headache—Estrone—prostate cancer	0.00104	0.00609	CcSEcCtD
Clorazepate—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00104	0.00609	CcSEcCtD
Clorazepate—Dizziness—Nilutamide—prostate cancer	0.00102	0.00597	CcSEcCtD
Clorazepate—Dizziness—Flutamide—prostate cancer	0.00102	0.00594	CcSEcCtD
Clorazepate—Insomnia—Bicalutamide—prostate cancer	0.00101	0.00589	CcSEcCtD
Clorazepate—Somnolence—Bicalutamide—prostate cancer	0.000992	0.00579	CcSEcCtD
Clorazepate—Asthenia—Degarelix—prostate cancer	0.00099	0.00579	CcSEcCtD
Clorazepate—Rash—Nilutamide—prostate cancer	0.000974	0.00569	CcSEcCtD
Clorazepate—Dermatitis—Nilutamide—prostate cancer	0.000973	0.00569	CcSEcCtD
Clorazepate—Rash—Flutamide—prostate cancer	0.00097	0.00567	CcSEcCtD
Clorazepate—Dermatitis—Flutamide—prostate cancer	0.000969	0.00566	CcSEcCtD
Clorazepate—Headache—Nilutamide—prostate cancer	0.000968	0.00566	CcSEcCtD
Clorazepate—Headache—Flutamide—prostate cancer	0.000964	0.00563	CcSEcCtD
Clorazepate—Fatigue—Bicalutamide—prostate cancer	0.000962	0.00562	CcSEcCtD
Clorazepate—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00096	0.00561	CcSEcCtD
Clorazepate—Tension—Goserelin—prostate cancer	0.000933	0.00545	CcSEcCtD
Clorazepate—Asthenia—Cabazitaxel—prostate cancer	0.000933	0.00545	CcSEcCtD
Clorazepate—Tension—Conjugated Estrogens—prostate cancer	0.000924	0.0054	CcSEcCtD
Clorazepate—Nervousness—Goserelin—prostate cancer	0.000923	0.0054	CcSEcCtD
Clorazepate—Feeling abnormal—Bicalutamide—prostate cancer	0.000919	0.00537	CcSEcCtD
Clorazepate—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000915	0.00535	CcSEcCtD
Clorazepate—Nervousness—Conjugated Estrogens—prostate cancer	0.000915	0.00534	CcSEcCtD
Clorazepate—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000915	0.00534	CcSEcCtD
Clorazepate—Dizziness—Degarelix—prostate cancer	0.000913	0.00533	CcSEcCtD
Clorazepate—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00091	0.00531	CcSEcCtD
Clorazepate—Drowsiness—Mitoxantrone—prostate cancer	0.000899	0.00525	CcSEcCtD
Clorazepate—Vision blurred—Goserelin—prostate cancer	0.000896	0.00524	CcSEcCtD
Clorazepate—Vision blurred—Conjugated Estrogens—prostate cancer	0.000888	0.00519	CcSEcCtD
Clorazepate—Rash—Degarelix—prostate cancer	0.00087	0.00508	CcSEcCtD
Clorazepate—Dermatitis—Degarelix—prostate cancer	0.000869	0.00508	CcSEcCtD
Clorazepate—Headache—Degarelix—prostate cancer	0.000865	0.00505	CcSEcCtD
Clorazepate—Dizziness—Cabazitaxel—prostate cancer	0.00086	0.00502	CcSEcCtD
Clorazepate—Oxazepam—UGT2B15—prostate cancer	0.000845	0.0879	CrCbGaD
Clorazepate—Headache—Cabazitaxel—prostate cancer	0.000815	0.00476	CcSEcCtD
Clorazepate—Fatigue—Ethinyl Estradiol—prostate cancer	0.000813	0.00475	CcSEcCtD
Clorazepate—Asthenia—Bicalutamide—prostate cancer	0.0008	0.00468	CcSEcCtD
Clorazepate—Dysarthria—Epirubicin—prostate cancer	0.000792	0.00463	CcSEcCtD
Clorazepate—Dry mouth—Goserelin—prostate cancer	0.000792	0.00463	CcSEcCtD
Clorazepate—Confusional state—Goserelin—prostate cancer	0.000782	0.00457	CcSEcCtD
Clorazepate—Diplopia—Capecitabine—prostate cancer	0.00078	0.00456	CcSEcCtD
Clorazepate—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000777	0.00454	CcSEcCtD
Clorazepate—Ataxia—Docetaxel—prostate cancer	0.000758	0.00443	CcSEcCtD
Clorazepate—Irritability—Capecitabine—prostate cancer	0.000745	0.00435	CcSEcCtD
Clorazepate—Tension—Estradiol—prostate cancer	0.00074	0.00432	CcSEcCtD
Clorazepate—Dizziness—Bicalutamide—prostate cancer	0.000738	0.00431	CcSEcCtD
Clorazepate—Ataxia—Capecitabine—prostate cancer	0.000734	0.00429	CcSEcCtD
Clorazepate—Oxazepam—CYP3A43—prostate cancer	0.000733	0.0762	CrCbGaD
Clorazepate—Dysarthria—Doxorubicin—prostate cancer	0.000733	0.00428	CcSEcCtD
Clorazepate—Nervousness—Estradiol—prostate cancer	0.000732	0.00428	CcSEcCtD
Clorazepate—Tremor—Estradiol—prostate cancer	0.000706	0.00413	CcSEcCtD
Clorazepate—Clonazepam—NAT2—prostate cancer	0.000704	0.0732	CrCbGaD
Clorazepate—Rash—Bicalutamide—prostate cancer	0.000703	0.00411	CcSEcCtD
Clorazepate—Dermatitis—Bicalutamide—prostate cancer	0.000703	0.00411	CcSEcCtD
Clorazepate—Insomnia—Goserelin—prostate cancer	0.000702	0.0041	CcSEcCtD
Clorazepate—Headache—Bicalutamide—prostate cancer	0.000699	0.00408	CcSEcCtD
Clorazepate—Insomnia—Conjugated Estrogens—prostate cancer	0.000695	0.00406	CcSEcCtD
Clorazepate—Somnolence—Goserelin—prostate cancer	0.00069	0.00403	CcSEcCtD
Clorazepate—Somnolence—Conjugated Estrogens—prostate cancer	0.000683	0.00399	CcSEcCtD
Clorazepate—Asthenia—Ethinyl Estradiol—prostate cancer	0.000676	0.00395	CcSEcCtD
Clorazepate—Fatigue—Goserelin—prostate cancer	0.000669	0.00391	CcSEcCtD
Clorazepate—Irritability—Prednisone—prostate cancer	0.000664	0.00388	CcSEcCtD
Clorazepate—Fatigue—Conjugated Estrogens—prostate cancer	0.000663	0.00387	CcSEcCtD
Clorazepate—Vision blurred—Mitoxantrone—prostate cancer	0.000662	0.00387	CcSEcCtD
Clorazepate—Feeling abnormal—Goserelin—prostate cancer	0.000639	0.00374	CcSEcCtD
Clorazepate—Dry mouth—Estradiol—prostate cancer	0.000628	0.00367	CcSEcCtD
Clorazepate—Dizziness—Ethinyl Estradiol—prostate cancer	0.000623	0.00364	CcSEcCtD
Clorazepate—Confusional state—Estradiol—prostate cancer	0.00062	0.00362	CcSEcCtD
Clorazepate—Rash—Ethinyl Estradiol—prostate cancer	0.000594	0.00347	CcSEcCtD
Clorazepate—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000594	0.00347	CcSEcCtD
Clorazepate—Headache—Ethinyl Estradiol—prostate cancer	0.000591	0.00345	CcSEcCtD
Clorazepate—Confusional state—Mitoxantrone—prostate cancer	0.000578	0.00338	CcSEcCtD
Clorazepate—Asthenia—Goserelin—prostate cancer	0.000557	0.00325	CcSEcCtD
Clorazepate—Insomnia—Estradiol—prostate cancer	0.000556	0.00325	CcSEcCtD
Clorazepate—Asthenia—Conjugated Estrogens—prostate cancer	0.000551	0.00322	CcSEcCtD
Clorazepate—Somnolence—Estradiol—prostate cancer	0.000547	0.0032	CcSEcCtD
Clorazepate—Diplopia—Epirubicin—prostate cancer	0.000544	0.00318	CcSEcCtD
Clorazepate—Fatigue—Estradiol—prostate cancer	0.00053	0.0031	CcSEcCtD
Clorazepate—Dizziness—Goserelin—prostate cancer	0.000513	0.003	CcSEcCtD
Clorazepate—Ataxia—Epirubicin—prostate cancer	0.000511	0.00299	CcSEcCtD
Clorazepate—Somnolence—Mitoxantrone—prostate cancer	0.00051	0.00298	CcSEcCtD
Clorazepate—Dizziness—Conjugated Estrogens—prostate cancer	0.000508	0.00297	CcSEcCtD
Clorazepate—Feeling abnormal—Estradiol—prostate cancer	0.000507	0.00296	CcSEcCtD
Clorazepate—Diplopia—Doxorubicin—prostate cancer	0.000503	0.00294	CcSEcCtD
Clorazepate—Fatigue—Mitoxantrone—prostate cancer	0.000494	0.00289	CcSEcCtD
Clorazepate—Rash—Goserelin—prostate cancer	0.000489	0.00286	CcSEcCtD
Clorazepate—Dermatitis—Goserelin—prostate cancer	0.000489	0.00286	CcSEcCtD
Clorazepate—Headache—Goserelin—prostate cancer	0.000486	0.00284	CcSEcCtD
Clorazepate—Rash—Conjugated Estrogens—prostate cancer	0.000485	0.00283	CcSEcCtD
Clorazepate—Dermatitis—Conjugated Estrogens—prostate cancer	0.000484	0.00283	CcSEcCtD
Clorazepate—Headache—Conjugated Estrogens—prostate cancer	0.000481	0.00281	CcSEcCtD
Clorazepate—Confusional state—Etoposide—prostate cancer	0.000481	0.00281	CcSEcCtD
Clorazepate—Ataxia—Doxorubicin—prostate cancer	0.000473	0.00276	CcSEcCtD
Clorazepate—Feeling abnormal—Mitoxantrone—prostate cancer	0.000472	0.00276	CcSEcCtD
Clorazepate—Vision blurred—Capecitabine—prostate cancer	0.000443	0.00259	CcSEcCtD
Clorazepate—Asthenia—Estradiol—prostate cancer	0.000441	0.00258	CcSEcCtD
Clorazepate—Tremor—Capecitabine—prostate cancer	0.00044	0.00257	CcSEcCtD
Clorazepate—Somnolence—Etoposide—prostate cancer	0.000424	0.00248	CcSEcCtD
Clorazepate—Drowsiness—Epirubicin—prostate cancer	0.000419	0.00245	CcSEcCtD
Clorazepate—Asthenia—Mitoxantrone—prostate cancer	0.000411	0.0024	CcSEcCtD
Clorazepate—Fatigue—Etoposide—prostate cancer	0.000411	0.0024	CcSEcCtD
Clorazepate—Dizziness—Estradiol—prostate cancer	0.000407	0.00238	CcSEcCtD
Clorazepate—Dry mouth—Docetaxel—prostate cancer	0.000404	0.00236	CcSEcCtD
Clorazepate—Confusional state—Docetaxel—prostate cancer	0.000399	0.00233	CcSEcCtD
Clorazepate—Vision blurred—Prednisone—prostate cancer	0.000395	0.00231	CcSEcCtD
Clorazepate—Feeling abnormal—Etoposide—prostate cancer	0.000393	0.0023	CcSEcCtD
Clorazepate—Clobazam—CYP2C18—prostate cancer	0.000392	0.0407	CrCbGaD
Clorazepate—Dry mouth—Capecitabine—prostate cancer	0.000391	0.00229	CcSEcCtD
Clorazepate—Rash—Estradiol—prostate cancer	0.000388	0.00227	CcSEcCtD
Clorazepate—Drowsiness—Doxorubicin—prostate cancer	0.000388	0.00227	CcSEcCtD
Clorazepate—Dermatitis—Estradiol—prostate cancer	0.000387	0.00226	CcSEcCtD
Clorazepate—Confusional state—Capecitabine—prostate cancer	0.000387	0.00226	CcSEcCtD
Clorazepate—Headache—Estradiol—prostate cancer	0.000385	0.00225	CcSEcCtD
Clorazepate—Rash—Mitoxantrone—prostate cancer	0.000361	0.00211	CcSEcCtD
Clorazepate—Dermatitis—Mitoxantrone—prostate cancer	0.000361	0.00211	CcSEcCtD
Clorazepate—Headache—Mitoxantrone—prostate cancer	0.000359	0.0021	CcSEcCtD
Clorazepate—Insomnia—Docetaxel—prostate cancer	0.000358	0.00209	CcSEcCtD
Clorazepate—Somnolence—Docetaxel—prostate cancer	0.000352	0.00206	CcSEcCtD
Clorazepate—Insomnia—Capecitabine—prostate cancer	0.000347	0.00203	CcSEcCtD
Clorazepate—Asthenia—Etoposide—prostate cancer	0.000342	0.002	CcSEcCtD
Clorazepate—Fatigue—Docetaxel—prostate cancer	0.000342	0.002	CcSEcCtD
Clorazepate—Fatigue—Capecitabine—prostate cancer	0.000331	0.00193	CcSEcCtD
Clorazepate—Feeling abnormal—Docetaxel—prostate cancer	0.000326	0.00191	CcSEcCtD
Clorazepate—Tension—Epirubicin—prostate cancer	0.000321	0.00188	CcSEcCtD
Clorazepate—Nervousness—Epirubicin—prostate cancer	0.000318	0.00186	CcSEcCtD
Clorazepate—Feeling abnormal—Capecitabine—prostate cancer	0.000316	0.00185	CcSEcCtD
Clorazepate—Dizziness—Etoposide—prostate cancer	0.000315	0.00184	CcSEcCtD
Clorazepate—Insomnia—Prednisone—prostate cancer	0.000309	0.00181	CcSEcCtD
Clorazepate—Vision blurred—Epirubicin—prostate cancer	0.000309	0.0018	CcSEcCtD
Clorazepate—Rash—Etoposide—prostate cancer	0.000301	0.00176	CcSEcCtD
Clorazepate—Dermatitis—Etoposide—prostate cancer	0.0003	0.00175	CcSEcCtD
Clorazepate—Headache—Etoposide—prostate cancer	0.000299	0.00174	CcSEcCtD
Clorazepate—Tension—Doxorubicin—prostate cancer	0.000297	0.00174	CcSEcCtD
Clorazepate—Fatigue—Prednisone—prostate cancer	0.000295	0.00172	CcSEcCtD
Clorazepate—Nervousness—Doxorubicin—prostate cancer	0.000294	0.00172	CcSEcCtD
Clorazepate—Vision blurred—Doxorubicin—prostate cancer	0.000286	0.00167	CcSEcCtD
Clorazepate—Asthenia—Docetaxel—prostate cancer	0.000284	0.00166	CcSEcCtD
Clorazepate—Feeling abnormal—Prednisone—prostate cancer	0.000282	0.00165	CcSEcCtD
Clorazepate—Asthenia—Capecitabine—prostate cancer	0.000275	0.00161	CcSEcCtD
Clorazepate—Dry mouth—Epirubicin—prostate cancer	0.000273	0.00159	CcSEcCtD
Clorazepate—Confusional state—Epirubicin—prostate cancer	0.000269	0.00157	CcSEcCtD
Clorazepate—CYP3A4—urine—prostate cancer	0.000262	0.125	CbGeAlD
Clorazepate—Dizziness—Docetaxel—prostate cancer	0.000262	0.00153	CcSEcCtD
Clorazepate—Alprazolam—CYP3A5—prostate cancer	0.000258	0.0268	CrCbGaD
Clorazepate—Dizziness—Capecitabine—prostate cancer	0.000254	0.00148	CcSEcCtD
Clorazepate—Dry mouth—Doxorubicin—prostate cancer	0.000252	0.00147	CcSEcCtD
Clorazepate—Fenbufen—PTGS2—prostate cancer	0.00025	0.026	CrCbGaD
Clorazepate—Rash—Docetaxel—prostate cancer	0.00025	0.00146	CcSEcCtD
Clorazepate—Dermatitis—Docetaxel—prostate cancer	0.00025	0.00146	CcSEcCtD
Clorazepate—Confusional state—Doxorubicin—prostate cancer	0.000249	0.00146	CcSEcCtD
Clorazepate—Headache—Docetaxel—prostate cancer	0.000248	0.00145	CcSEcCtD
Clorazepate—Asthenia—Prednisone—prostate cancer	0.000245	0.00143	CcSEcCtD
Clorazepate—Rash—Capecitabine—prostate cancer	0.000242	0.00141	CcSEcCtD
Clorazepate—Insomnia—Epirubicin—prostate cancer	0.000242	0.00141	CcSEcCtD
Clorazepate—Dermatitis—Capecitabine—prostate cancer	0.000242	0.00141	CcSEcCtD
Clorazepate—Headache—Capecitabine—prostate cancer	0.00024	0.0014	CcSEcCtD
Clorazepate—Somnolence—Epirubicin—prostate cancer	0.000238	0.00139	CcSEcCtD
Clorazepate—Fatigue—Epirubicin—prostate cancer	0.00023	0.00135	CcSEcCtD
Clorazepate—Diazepam—CYP2C18—prostate cancer	0.000229	0.0238	CrCbGaD
Clorazepate—Dizziness—Prednisone—prostate cancer	0.000226	0.00132	CcSEcCtD
Clorazepate—Insomnia—Doxorubicin—prostate cancer	0.000224	0.00131	CcSEcCtD
Clorazepate—Feeling abnormal—Epirubicin—prostate cancer	0.00022	0.00129	CcSEcCtD
Clorazepate—Somnolence—Doxorubicin—prostate cancer	0.00022	0.00128	CcSEcCtD
Clorazepate—Midazolam—SLC22A1—prostate cancer	0.000218	0.0227	CrCbGaD
Clorazepate—Oxaprozin—PTGS2—prostate cancer	0.000217	0.0226	CrCbGaD
Clorazepate—Bromazepam—CYP2E1—prostate cancer	0.000216	0.0224	CrCbGaD
Clorazepate—Rash—Prednisone—prostate cancer	0.000215	0.00126	CcSEcCtD
Clorazepate—Dermatitis—Prednisone—prostate cancer	0.000215	0.00126	CcSEcCtD
Clorazepate—Headache—Prednisone—prostate cancer	0.000214	0.00125	CcSEcCtD
Clorazepate—Bromazepam—CYP2C19—prostate cancer	0.000214	0.0222	CrCbGaD
Clorazepate—Fatigue—Doxorubicin—prostate cancer	0.000213	0.00125	CcSEcCtD
Clorazepate—Feeling abnormal—Doxorubicin—prostate cancer	0.000204	0.00119	CcSEcCtD
Clorazepate—TSPO—prostate gland—prostate cancer	0.000203	0.0969	CbGeAlD
Clorazepate—Clonazepam—CYP2E1—prostate cancer	0.000202	0.021	CrCbGaD
Clorazepate—Asthenia—Epirubicin—prostate cancer	0.000192	0.00112	CcSEcCtD
Clorazepate—Clozapine—CYP1B1—prostate cancer	0.000187	0.0194	CrCbGaD
Clorazepate—GABRB3—prostate gland—prostate cancer	0.000184	0.088	CbGeAlD
Clorazepate—Oxazepam—CYP3A5—prostate cancer	0.000184	0.0191	CrCbGaD
Clorazepate—Asthenia—Doxorubicin—prostate cancer	0.000177	0.00104	CcSEcCtD
Clorazepate—Dizziness—Epirubicin—prostate cancer	0.000177	0.00103	CcSEcCtD
Clorazepate—Midazolam—CYP3A5—prostate cancer	0.000176	0.0183	CrCbGaD
Clorazepate—Clobazam—CYP2C19—prostate cancer	0.000176	0.0183	CrCbGaD
Clorazepate—TSPO—seminal vesicle—prostate cancer	0.000171	0.082	CbGeAlD
Clorazepate—Rash—Epirubicin—prostate cancer	0.000168	0.000984	CcSEcCtD
Clorazepate—Dermatitis—Epirubicin—prostate cancer	0.000168	0.000984	CcSEcCtD
Clorazepate—Headache—Epirubicin—prostate cancer	0.000167	0.000978	CcSEcCtD
Clorazepate—Dizziness—Doxorubicin—prostate cancer	0.000164	0.000955	CcSEcCtD
Clorazepate—Rash—Doxorubicin—prostate cancer	0.000156	0.000911	CcSEcCtD
Clorazepate—Dermatitis—Doxorubicin—prostate cancer	0.000156	0.00091	CcSEcCtD
Clorazepate—Headache—Doxorubicin—prostate cancer	0.000155	0.000905	CcSEcCtD
Clorazepate—Diazepam—CYP3A5—prostate cancer	0.000151	0.0157	CrCbGaD
Clorazepate—TSPO—epithelium—prostate cancer	0.000149	0.0712	CbGeAlD
Clorazepate—Nitrazepam—CYP2E1—prostate cancer	0.000147	0.0152	CrCbGaD
Clorazepate—Clozapine—CYP2A6—prostate cancer	0.000144	0.015	CrCbGaD
Clorazepate—Adinazolam—CYP2C19—prostate cancer	0.000143	0.0149	CrCbGaD
Clorazepate—GABRA5—testis—prostate cancer	0.000139	0.0665	CbGeAlD
Clorazepate—TSPO—renal system—prostate cancer	0.000138	0.0661	CbGeAlD
Clorazepate—Bromazepam—CYP3A4—prostate cancer	0.000136	0.0141	CrCbGaD
Clorazepate—TSPO—urethra—prostate cancer	0.000136	0.0649	CbGeAlD
Clorazepate—Chlordiazepoxide—CYP3A4—prostate cancer	0.000132	0.0137	CrCbGaD
Clorazepate—GABRA3—testis—prostate cancer	0.000129	0.0619	CbGeAlD
Clorazepate—Clonazepam—CYP3A4—prostate cancer	0.000127	0.0132	CrCbGaD
Clorazepate—Temazepam—CYP2C19—prostate cancer	0.000123	0.0128	CrCbGaD
Clorazepate—Midazolam—CYP2E1—prostate cancer	0.000121	0.0126	CrCbGaD
Clorazepate—Flurbiprofen—PTGS2—prostate cancer	0.000117	0.0122	CrCbGaD
Clorazepate—Clobazam—CYP3A4—prostate cancer	0.000112	0.0116	CrCbGaD
Clorazepate—Alprazolam—CYP3A4—prostate cancer	0.000112	0.0116	CrCbGaD
Clorazepate—GABRB2—testis—prostate cancer	0.000106	0.0505	CbGeAlD
Clorazepate—TSPO—bone marrow—prostate cancer	0.000104	0.0499	CbGeAlD
Clorazepate—Diazepam—CYP2E1—prostate cancer	0.000104	0.0108	CrCbGaD
Clorazepate—Diazepam—CYP2C19—prostate cancer	0.000103	0.0107	CrCbGaD
Clorazepate—Clozapine—CYP2E1—prostate cancer	0.000102	0.0106	CrCbGaD
Clorazepate—Clozapine—CYP2C19—prostate cancer	0.000101	0.0105	CrCbGaD
Clorazepate—Clozapine—CYP1A1—prostate cancer	0.000101	0.0105	CrCbGaD
Clorazepate—Estazolam—CYP3A4—prostate cancer	9.57e-05	0.00995	CrCbGaD
Clorazepate—Nitrazepam—CYP3A4—prostate cancer	9.23e-05	0.0096	CrCbGaD
Clorazepate—Adinazolam—CYP3A4—prostate cancer	9.11e-05	0.00947	CrCbGaD
Clorazepate—TSPO—testis—prostate cancer	8.93e-05	0.0427	CbGeAlD
Clorazepate—Prazepam—CYP3A4—prostate cancer	8.81e-05	0.00916	CrCbGaD
Clorazepate—GABRB3—testis—prostate cancer	8.11e-05	0.0388	CbGeAlD
Clorazepate—Oxazepam—CYP3A4—prostate cancer	7.95e-05	0.00827	CrCbGaD
Clorazepate—Temazepam—CYP3A4—prostate cancer	7.85e-05	0.00816	CrCbGaD
Clorazepate—Midazolam—CYP3A4—prostate cancer	7.61e-05	0.00792	CrCbGaD
Clorazepate—GABRA2—lymph node—prostate cancer	6.99e-05	0.0334	CbGeAlD
Clorazepate—Diazepam—CYP3A4—prostate cancer	6.52e-05	0.00678	CrCbGaD
Clorazepate—TSPO—lymph node—prostate cancer	6.47e-05	0.0309	CbGeAlD
Clorazepate—Clozapine—CYP3A4—prostate cancer	6.44e-05	0.0067	CrCbGaD
Clorazepate—CYP3A4—renal system—prostate cancer	6.42e-05	0.0307	CbGeAlD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.33e-05	0.000918	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—JAK2—prostate cancer	6.31e-05	0.000916	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—GNG5—prostate cancer	6.31e-05	0.000916	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	6.3e-05	0.000914	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.22e-05	0.000903	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	6.18e-05	0.000898	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.18e-05	0.000897	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—GNG5—prostate cancer	6.13e-05	0.00089	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.06e-05	0.000881	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	6.02e-05	0.000874	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—GNG5—prostate cancer	6.02e-05	0.000874	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	6e-05	0.000871	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	5.97e-05	0.000867	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—GNG5—prostate cancer	5.91e-05	0.000859	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	5.89e-05	0.000855	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—GNG5—prostate cancer	5.87e-05	0.000853	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	5.84e-05	0.000847	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—COMT—prostate cancer	5.82e-05	0.000845	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTA3—prostate cancer	5.77e-05	0.000838	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—GNG5—prostate cancer	5.77e-05	0.000838	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	5.7e-05	0.000828	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	5.69e-05	0.000826	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—CASP3—prostate cancer	5.51e-05	0.0008	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	5.44e-05	0.00079	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	5.4e-05	0.000785	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.38e-05	0.000781	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	5.36e-05	0.000779	CbGpPWpGaD
Clorazepate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	5.33e-05	0.000774	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—CTNNB1—prostate cancer	5.31e-05	0.000771	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.3e-05	0.00077	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTA4—prostate cancer	5.28e-05	0.000766	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	5.28e-05	0.000766	CbGpPWpGaD
Clorazepate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	5.26e-05	0.000764	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.22e-05	0.000758	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	5.2e-05	0.000756	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	5.18e-05	0.000752	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTA2—prostate cancer	5.14e-05	0.000747	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.13e-05	0.000745	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—MDM2—prostate cancer	5.08e-05	0.000738	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	5.08e-05	0.000737	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.07e-05	0.000736	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	5.04e-05	0.000732	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.04e-05	0.000732	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	5.01e-05	0.000727	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.01e-05	0.000727	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTA1—prostate cancer	4.96e-05	0.00072	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—MDM2—prostate cancer	4.94e-05	0.000717	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.93e-05	0.000715	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.92e-05	0.000714	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—NAT2—prostate cancer	4.9e-05	0.000712	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTO1—prostate cancer	4.9e-05	0.000712	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—MDM2—prostate cancer	4.85e-05	0.000704	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	4.84e-05	0.000702	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	4.84e-05	0.000702	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.84e-05	0.000702	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.84e-05	0.000702	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—SRC—prostate cancer	4.8e-05	0.000697	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—MDM2—prostate cancer	4.77e-05	0.000692	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.75e-05	0.00069	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—MDM2—prostate cancer	4.73e-05	0.000687	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.72e-05	0.000686	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	4.7e-05	0.000683	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.7e-05	0.000682	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—MDM2—prostate cancer	4.65e-05	0.000675	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	4.64e-05	0.000673	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.64e-05	0.000673	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	4.63e-05	0.000673	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—STAT3—prostate cancer	4.63e-05	0.000672	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.61e-05	0.00067	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.53e-05	0.000658	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.51e-05	0.000654	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	4.44e-05	0.000644	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.42e-05	0.000642	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	4.37e-05	0.000635	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	4.32e-05	0.000628	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	4.31e-05	0.000626	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.3e-05	0.000624	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	4.28e-05	0.000621	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.27e-05	0.00062	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.15e-05	0.000603	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	4.11e-05	0.000597	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.08e-05	0.000592	CbGpPWpGaD
Clorazepate—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	4.07e-05	0.000591	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—RXRA—prostate cancer	4.06e-05	0.00059	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	4.06e-05	0.00059	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.05e-05	0.000589	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.01e-05	0.000582	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.98e-05	0.000578	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	3.97e-05	0.000577	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	3.95e-05	0.000573	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—HPGDS—prostate cancer	3.92e-05	0.000569	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.91e-05	0.000567	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	3.9e-05	0.000566	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—MDM2—prostate cancer	3.89e-05	0.000565	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	3.88e-05	0.000563	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.87e-05	0.000561	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	3.84e-05	0.000558	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.81e-05	0.000553	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTT1—prostate cancer	3.8e-05	0.000552	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—RXRA—prostate cancer	3.79e-05	0.00055	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—MDM2—prostate cancer	3.78e-05	0.000549	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	3.76e-05	0.000547	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	3.76e-05	0.000546	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.72e-05	0.00054	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—MDM2—prostate cancer	3.72e-05	0.000539	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—MDM2—prostate cancer	3.65e-05	0.00053	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—MDM2—prostate cancer	3.63e-05	0.000527	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	3.61e-05	0.000524	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	3.6e-05	0.000523	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—MDM2—prostate cancer	3.56e-05	0.000517	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	3.55e-05	0.000516	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.43e-05	0.000498	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.42e-05	0.000496	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.25e-05	0.000472	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.2e-05	0.000464	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.15e-05	0.000458	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—MDM2—prostate cancer	3.11e-05	0.000452	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—PPARA—prostate cancer	3.1e-05	0.000451	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.03e-05	0.00044	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	3.02e-05	0.000438	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	2.99e-05	0.000434	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—AKT1—prostate cancer	2.98e-05	0.000433	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.96e-05	0.00043	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.93e-05	0.000426	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.91e-05	0.000423	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.89e-05	0.00042	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.89e-05	0.00042	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.85e-05	0.000414	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.84e-05	0.000412	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.81e-05	0.000408	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.75e-05	0.000399	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—COMT—prostate cancer	2.65e-05	0.000385	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.64e-05	0.000383	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.61e-05	0.000379	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	2.6e-05	0.000378	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.6e-05	0.000378	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.48e-05	0.00036	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.46e-05	0.000358	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.42e-05	0.000352	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.39e-05	0.000348	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.39e-05	0.000347	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.35e-05	0.000341	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.31e-05	0.000336	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.3e-05	0.000333	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.3e-05	0.000333	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HAO1—prostate cancer	2.27e-05	0.000329	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.26e-05	0.000329	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.25e-05	0.000327	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.97e-05	0.000286	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TST—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GRHL1—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PSAT1—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CSAD—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ADI1—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CBR1—prostate cancer	1.85e-05	0.000268	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GRHPR—prostate cancer	1.72e-05	0.000249	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CKMT2—prostate cancer	1.72e-05	0.000249	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.72e-05	0.000249	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.72e-05	0.000249	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—AOX1—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—RFK—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NAGLU—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PGAM2—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTM3—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.61e-05	0.000234	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—AMACR—prostate cancer	1.53e-05	0.000222	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—DEGS1—prostate cancer	1.53e-05	0.000222	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NAT1—prostate cancer	1.53e-05	0.000222	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.53e-05	0.000222	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.53e-05	0.000222	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.46e-05	0.000212	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.3e-05	0.000189	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HPGD—prostate cancer	1.3e-05	0.000189	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.22e-05	0.000178	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MTAP—prostate cancer	1.19e-05	0.000173	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.19e-05	0.000173	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.16e-05	0.000168	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.16e-05	0.000168	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ACSL4—prostate cancer	1.11e-05	0.000161	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.11e-05	0.000161	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ARG2—prostate cancer	1.06e-05	0.000154	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PHGDH—prostate cancer	1.06e-05	0.000154	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—UMPS—prostate cancer	1.06e-05	0.000154	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—LDHB—prostate cancer	1.04e-05	0.000151	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.02e-05	0.000148	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PDHA1—prostate cancer	9.86e-06	0.000143	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTA3—prostate cancer	9.86e-06	0.000143	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—UCP3—prostate cancer	9.86e-06	0.000143	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TCN2—prostate cancer	9.86e-06	0.000143	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.41e-06	0.000137	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.41e-06	0.000137	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTA4—prostate cancer	9.02e-06	0.000131	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.02e-06	0.000131	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTA2—prostate cancer	8.79e-06	0.000128	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.69e-06	0.000126	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ABCG5—prostate cancer	8.69e-06	0.000126	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTA1—prostate cancer	8.48e-06	0.000123	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.39e-06	0.000122	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTO1—prostate cancer	8.39e-06	0.000122	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NAT2—prostate cancer	8.39e-06	0.000122	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.04e-06	0.000117	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—LRP2—prostate cancer	8.04e-06	0.000117	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PLCB2—prostate cancer	8.04e-06	0.000117	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—P4HB—prostate cancer	7.89e-06	0.000115	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.67e-06	0.000111	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.48e-06	0.000109	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MED12—prostate cancer	7.36e-06	0.000107	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GNG5—prostate cancer	7.3e-06	0.000106	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NCOA3—prostate cancer	7.03e-06	0.000102	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HPGDS—prostate cancer	6.71e-06	9.74e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.66e-06	9.68e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTT1—prostate cancer	6.5e-06	9.44e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ACHE—prostate cancer	6.5e-06	9.44e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.43e-06	9.33e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.25e-06	9.08e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PRKACB—prostate cancer	6.22e-06	9.03e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.16e-06	8.94e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NCOA2—prostate cancer	5.87e-06	8.52e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.6e-06	8.13e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.47e-06	7.94e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NQO1—prostate cancer	5.41e-06	7.85e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TH—prostate cancer	5.33e-06	7.74e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.18e-06	7.52e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GGT1—prostate cancer	5.02e-06	7.29e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NCOA1—prostate cancer	4.94e-06	7.18e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.87e-06	7.07e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—RXRA—prostate cancer	4.7e-06	6.83e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—COMT—prostate cancer	4.53e-06	6.58e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTP1—prostate cancer	4.51e-06	6.55e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ITPR1—prostate cancer	4.44e-06	6.44e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TYMS—prostate cancer	4.19e-06	6.09e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTM1—prostate cancer	4.14e-06	6.02e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—LPL—prostate cancer	4.07e-06	5.9e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.93e-06	5.7e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ERCC2—prostate cancer	3.9e-06	5.66e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—MTHFR—prostate cancer	3.66e-06	5.32e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PPARA—prostate cancer	3.59e-06	5.22e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CAV1—prostate cancer	3.38e-06	4.9e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.08e-06	4.47e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—INS—prostate cancer	2.91e-06	4.23e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CREBBP—prostate cancer	2.85e-06	4.14e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.7e-06	3.93e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NOS3—prostate cancer	2.55e-06	3.71e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.36e-06	3.42e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PTGS2—prostate cancer	2.34e-06	3.39e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PTEN—prostate cancer	2.04e-06	2.96e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—EP300—prostate cancer	1.94e-06	2.82e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.44e-06	2.09e-05	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—AKT1—prostate cancer	1.17e-06	1.7e-05	CbGpPWpGaD
